A0580

Arachidonylethanolamide

≥97.0% (TLC), oil

• Sinónimos: Anandamide (20:4, n-6), AEA, Anandamide, Arachidonic acid N-(hydroxyethyl)amide
• Fórmula empírica (notación de Hill): C₂₂H₃₇NO₂
• Número CAS: 94421-68-8
• Peso molecular: 347.53
• NACRES: NA.25
• PubChem Substance ID: 24890438
• UNSPSC Code: 12352211
• MDL number: MFCD00153766

Propiedades

• Quality Segment: 200
• assay: ≥97.0% (TLC)
• form: oil
• drug control: regulated under CDSA - not available from Sigma-Aldrich Canada
• color: colorless to light yellow
• solubility: ethanol: soluble
• density: 0.92 g/mL at 25 °C (lit.)
• lipid type: omega FAs
• shipped in: dry ice
• storage temp.: −20°C
• SMILES string: O=C(CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)NCCO
• InChI: 1S/C22H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-22(25)23-20-21-24/h6-7,9-10,12-13,15-16,24H,2-5,8,11,14,17-21H2,1H3,(H,23,25)/b7-6-,10-9-,13-12-,16-15-
• InChI key: LGEQQWMQCRIYKG-DOFZRALJSA-N
• Gene Information: rat ... Cnr1(25248)

Descripción

Application

• Interactions Between Endocannabinoid and Endogenous Opioid Systems Prospectively Influence Postoperative Opioid Use in Pregnant Patients Undergoing Cesarean Delivery: Investigates Arachidonylethanolamide′s interactions with opioid systems, providing insights that could lead to better management of postoperative pain and opioid use (Stone et al., 2024).

Biochem/physiol Actions

An arachidonic acid derivative that is an endogenous ligand for the CB cannabinoid receptor and for the VR1 vanilloid receptor. Inhibits calcium currents in neuroblastomas and neurons. Activates the MAP kinase signaling pathway. Inhibits proliferation and induces apoptosis of lymphocytes and human breast cancer cells.

Disclaimer

Protect from light and moisture.

Información de seguridad

• Clase de almacenamiento: 11 - Combustible Solids
• flash_point_f: Not applicable
• flash_point_c: Not applicable
• ppe: Eyeshields, Gloves, type N95 (US)